Breast Cancer Foundation NZ
A Vaccine for HER2+ advanced breast cancer
What is the problem and who is affected?
HER2+ breast cancer is more likely to spread throughout the body than some other breast cancers. Researchers around the world have been trying to develop vaccines to prevent this spread, but so far, they’re not really working.
What is this research hoping to achieve?
Dr Robert Weinkove at Malaghan Institute of Medical Research in Wellington has teamed up with BCFNZ Ferrier Breast Cancer Research Progamme at Victoria University to develop new, more effective anti-HER2 vaccines. They will use a $250,000 grant from BCFNZ’s partnership with the Health Research Council and Breast Cancer Cure to test their new vaccines on metastatic breast cancer cell lines, to see if they can stop the cancer spreading. If that is successful, they will test whether the vaccines produce an immune response in cells from people with and without breast cancer.
-
SeptemberResearch Grant
Tackling side-effects of chemotherapy
-
SeptemberResearch Grant
Virus-based vaccine for TNBC
-
AugustResearch Grant
Improving equality in breast cancer care
-
AugustResearch Grant
Analysis of DCIS data in the Breast Cancer Foundation National Register
-
AugustResearch Grant
Gaps in the provision of radiotherapy for early breast cancer
-
AugustResearch Grant
Immunotherapy in breast cancer
-
JulyResearch Grant
A Vaccine for HER2+ advanced breast cancer
-
JulyResearch Grant
Finding a targeted drug for triple negative breast cancer
-
JuneResearch Grant
Using fat stem cells to improve breast reconstruction
-
JuneResearch Grant
Digital pathology for more accurate breast cancer diagnosis
-
April
Ronald Kay Science Fellowship for 2018
-
AprilBelinda Scott Fellowship
BCFNZ Belinda Scott Clinical Fellowship for 2018
-
MarchResearch Grant
Year 2: Five-year research partnership targets breast cancer vaccine